Sidra Medicine Authorized as Certification Examination Site by the International Academy of Cytology


Sidra Medicine will become the first institution in the State of Qatar to offer cytopathology certification examinations for Qataris and other candidates wanting to secure professional credentials to practice as diagnostic cytologists.

Sidra Medicine has been authorized by the International Academy of Cytology (IAC) to organize and host inaugural certification examinations for cytologists in Qatar. The IAC is a scientific, non-profit organization for cytopathologists, cytotechnologists and other professionals concerned with the discipline of clinical cytopathology; it is also the foremost organization to issue professional credentials on a global scale.

Diagnostic cytologists prepare and methodically analyze samples to assess various associated diseases and conditions as well as to support screening services and provide enhanced patient care and treatment.

Cytopathology is a specialized discipline of diagnostic medicine whereby cells in human samples are analyzed predominantly for the detection of cancer. Other follow up services by Cytopathology pertain to the surveillance and management of the cancer cells, its likely spread, and the effectiveness of treatment. For example, a primary target for cytopathology is the detection of early cellular changes that may reflect the development of cervical cancer through the Pap test screening service.

Seven medical professionals from both the public and private health sector in Qatar, and elsewhere, are currently enrolled to sit for the inaugural certification examinations which will be conducted at Sidra Medicine on August 17, 2017.  The examinations encompass all aspects of comprehensive cytopathology; inclusive of theory, digital cytopathology, and practical test cases. Particularly in accredited cytopathology services, diagnostic cytologists need to be certified and credentialed in order to report diagnostic findings along with cytopathologists. This is a fundamental requirement at Sidra Medicine.

The examinations will be led by senior diagnostic cytologist and fellow of the International Academy of Cytology, Nikolaos Chantziantoniou, who was in charge of getting Sidra Medicine authorized as an examination site for the IAC.  “Medical education is one of the three pillars of Sidra Medicine and by qualifying the organization to host IAC examinations is a significant historical milestone in support of robust and specialized academic programs in the country. For those working in Qatar, they now have access to cutting-edge technology, laboratories and experts in the region. We hope more medical professionals specializing in clinical cytopathology will be encouraged to seek prestigious credentials in the field.”

The examinations at Sidra Medicine are open to qualified candidates internationally. Sidra Medicine is also currently in the process of reviewing the option of conducting future IAC examinations along with other distinguished institutions around the world.